GEHC Expands Theranostics Imaging With 5 Global Collaborations
Here's What to Expect From GE HealthCare’s Next Earnings Report
GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance
GE HealthCare Technologies (GEHC) Could Be 19% Undervalued As Imaging Push Gains Ground
Did Cyclotron CE Mark Just Shift GE HealthCare's (GEHC) Investment Narrative?
GE HealthCare (GEHC) Stock May Be Undervalued Despite The $945 Million Deal
Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow
GE HealthCare secures CE mark for MINItrace Magni cyclotron
GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68
GE HealthCare (GEHC): Buy, Sell, or Hold Post Q2 Earnings?
BTIG Maintains Buy on GE HealthCare Techs, Lowers Price Target to $75
GE HealthCare: M&A And Execution To Drive A Value Re-Rating
GE HealthCare to announce third quarter 2026 results on October 28, 2026
Barclays Initiates Coverage On GE HealthCare Techs with Overweight Rating, Announces Price Target of $85
GE Healthcare's Sofie Deal to Vertically Integrate Radiopharma Portfolio, Needham Says
GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal
GE Healthcare to Buy Sofie Biosciences for $945 Million
Citigroup Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $71
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.